nodes	percent_of_prediction	percent_of_DWPC	metapath
Droperidol—ADRA1A—Endothelin Pathways—ADCY10—nephrolithiasis	0.139	0.139	CbGpPWpGaD
Droperidol—DRD2—Monoamine GPCRs—CHRM3—nephrolithiasis	0.06	0.06	CbGpPWpGaD
Droperidol—HTR2A—Monoamine GPCRs—CHRM3—nephrolithiasis	0.059	0.059	CbGpPWpGaD
Droperidol—ADRA1A—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0578	0.0578	CbGpPWpGaD
Droperidol—DRD2—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0504	0.0504	CbGpPWpGaD
Droperidol—HTR2A—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0496	0.0496	CbGpPWpGaD
Droperidol—ADRA1A—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0486	0.0486	CbGpPWpGaD
Droperidol—ADRA1A—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.0354	0.0354	CbGpPWpGaD
Droperidol—HTR2A—GPCRs, Other—CHRM3—nephrolithiasis	0.0262	0.0262	CbGpPWpGaD
Droperidol—DRD2—G alpha (i) signalling events—RGS14—nephrolithiasis	0.0255	0.0255	CbGpPWpGaD
Droperidol—HTR2A—G alpha (q) signalling events—DGKH—nephrolithiasis	0.0204	0.0204	CbGpPWpGaD
Droperidol—ADRA1A—G alpha (q) signalling events—DGKH—nephrolithiasis	0.02	0.02	CbGpPWpGaD
Droperidol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.0182	0.0182	CbGpPWpGaD
Droperidol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.0179	0.0179	CbGpPWpGaD
Droperidol—ADRA1A—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.0173	0.0173	CbGpPWpGaD
Droperidol—HTR2A—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.0147	0.0147	CbGpPWpGaD
Droperidol—ADRA1A—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.0144	0.0144	CbGpPWpGaD
Droperidol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.0132	0.0132	CbGpPWpGaD
Droperidol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.0129	0.0129	CbGpPWpGaD
Droperidol—DRD2—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.0116	0.0116	CbGpPWpGaD
Droperidol—HTR2A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.0114	0.0114	CbGpPWpGaD
Droperidol—ADRA1A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.0112	0.0112	CbGpPWpGaD
Droperidol—DRD2—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00992	0.00992	CbGpPWpGaD
Droperidol—HTR2A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00976	0.00976	CbGpPWpGaD
Droperidol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00956	0.00956	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—RGS14—nephrolithiasis	0.00874	0.00874	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—RGS14—nephrolithiasis	0.0086	0.0086	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—RGS14—nephrolithiasis	0.00842	0.00842	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—RGS14—nephrolithiasis	0.00794	0.00794	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—RGS14—nephrolithiasis	0.00781	0.00781	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—RGS14—nephrolithiasis	0.00765	0.00765	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—CHRM3—nephrolithiasis	0.00755	0.00755	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—CHRM3—nephrolithiasis	0.00743	0.00743	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—CHRM3—nephrolithiasis	0.00728	0.00728	CbGpPWpGaD
Droperidol—DRD2—GPCR ligand binding—PTH—nephrolithiasis	0.00691	0.00691	CbGpPWpGaD
Droperidol—HTR2A—GPCR ligand binding—PTH—nephrolithiasis	0.0068	0.0068	CbGpPWpGaD
Droperidol—ADRA1A—GPCR ligand binding—PTH—nephrolithiasis	0.00666	0.00666	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—DGKH—nephrolithiasis	0.0059	0.0059	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—DGKH—nephrolithiasis	0.00581	0.00581	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—DGKH—nephrolithiasis	0.00569	0.00569	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—ADCY10—nephrolithiasis	0.00552	0.00552	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—ADCY10—nephrolithiasis	0.00543	0.00543	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—DGKH—nephrolithiasis	0.00536	0.00536	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—ADCY10—nephrolithiasis	0.00531	0.00531	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—DGKH—nephrolithiasis	0.00528	0.00528	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—DGKH—nephrolithiasis	0.00517	0.00517	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—RGS14—nephrolithiasis	0.00469	0.00469	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—RGS14—nephrolithiasis	0.00461	0.00461	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—RGS14—nephrolithiasis	0.00452	0.00452	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00427	0.00427	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.0042	0.0042	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00411	0.00411	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—PTH—nephrolithiasis	0.0039	0.0039	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—CHRM3—nephrolithiasis	0.00388	0.00388	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—PTH—nephrolithiasis	0.00384	0.00384	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—CHRM3—nephrolithiasis	0.00381	0.00381	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—PTH—nephrolithiasis	0.00376	0.00376	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—CHRM3—nephrolithiasis	0.00374	0.00374	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—PTH—nephrolithiasis	0.00355	0.00355	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—PTH—nephrolithiasis	0.00349	0.00349	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—PTH—nephrolithiasis	0.00342	0.00342	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00317	0.00317	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—DGKH—nephrolithiasis	0.00317	0.00317	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00312	0.00312	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—DGKH—nephrolithiasis	0.00312	0.00312	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00305	0.00305	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—DGKH—nephrolithiasis	0.00305	0.00305	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CHRM3—nephrolithiasis	0.00229	0.00229	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CHRM3—nephrolithiasis	0.00225	0.00225	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CHRM3—nephrolithiasis	0.00221	0.00221	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PTH—nephrolithiasis	0.00209	0.00209	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PTH—nephrolithiasis	0.00206	0.00206	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PTH—nephrolithiasis	0.00202	0.00202	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—SPP1—nephrolithiasis	0.00105	0.00105	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—SPP1—nephrolithiasis	0.00103	0.00103	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—SPP1—nephrolithiasis	0.00101	0.00101	CbGpPWpGaD
